Recent developments in tubulin polymerization inhibitors: an overview

R Kaur, G Kaur, RK Gill, R Soni, J Bariwal - European journal of medicinal …, 2014 - Elsevier
Microtubules are protein biopolymers formed through polymerization of heterodimers of α-
and β-tubulins. Disruption of microtubules can induce cell cycle arrest in G 2-M phase and …

Discovery of novel benzimidazole and indazole analogues as tubulin polymerization inhibitors with potent anticancer activities

Y Ren, Y Wang, G Li, Z Zhang, L Ma… - Journal of Medicinal …, 2021 - ACS Publications
Novel indazole and benzimidazole analogues were designed and synthesized as tubulin
inhibitors with potent antiproliferative activities. Among them, compound 12b exhibited the …

Indole derivatives as tubulin polymerization inhibitors for the development of promising anticancer agents

Y Hong, YY Zhu, Q He, SX Gu - Bioorganic & medicinal chemistry, 2022 - Elsevier
The α-and β-tubulins are the major polypeptide components of microtubules (MTs), which
are attractive targets for anticancer drug development. Indole derivatives display a variety of …

Tubulin inhibitors: a patent review

YM Liu, HL Chen, HY Lee, JP Liou - Expert opinion on therapeutic …, 2014 - Taylor & Francis
Introduction: Microtubules play an important role in several cellular processes, particularly in
the formation of the mitotic spindle during the process of mitosis. These highly dynamic …

Tubulin inhibitors as novel anticancer agents: an overview on patents (2013-2018)

K Haider, S Rahaman, MS Yar… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: About 20 patents have been published from 2013 to 2018 for developing
advanced cancer therapeutics by targeting tubulin polymerization. Currently, there are …

[HTML][HTML] Recent advances of tubulin inhibitors targeting the colchicine binding site for cancer therapy

M Hawash - Biomolecules, 2022 - mdpi.com
Cancer accounts for numerous deaths each year, and it is one of the most common causes
of death worldwide, despite many breakthroughs in the discovery of novel anticancer …

Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2, 7-diaryl-[1, 2, 4] triazolo [1, 5-a] …

XS Huo, XE Jian, J Ou-Yang, L Chen, F Yang… - European Journal of …, 2021 - Elsevier
Abstract By removing 5-methyl and 6-acetyl groups in our previously reported compound 3,
we designed a series of novel 2, 7-diaryl-[1, 2, 4] triazolo [1, 5-a] pyrimidine derivatives as …

Heterocyclic-fused pyrimidines as novel tubulin polymerization inhibitors targeting the colchicine binding site: structural basis and antitumor efficacy

S Banerjee, KE Arnst, Y Wang, G Kumar… - Journal of medicinal …, 2018 - ACS Publications
We report the design, synthesis, and biological evaluation of heterocyclic-fused pyrimidines
as tubulin polymerization inhibitors targeting the colchicine binding site with significantly …

Design, synthesis, and bioevaluation of pyrazolo [1, 5-a] pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent …

G Li, Y Wang, L Li, Y Ren, X Deng, J Liu… - European Journal of …, 2020 - Elsevier
Abstract A series of Pyrazolo [1, 5-a] Pyrimidine analogs were designed and synthesized as
novel tubulin inhibitors. Among them, compounds 1a and 1b showed the highest …

Tubulins-the target for anticancer therapy

NG Vindya, N Sharma, M Yadav… - Current Topics in …, 2015 - ingentaconnect.com
Tubulin has picked up great focus as a major target in drug discovery and consequently,
tubulin inhibitors have pulling in a considerable attention as anticancer agents. Numerable …